Abstract:Mitochondrial dynamics have critical roles in aging, and their impairment represents a prominent risk factor for myocardial dysfunction. Mitochondrial deacety-lase sirtuin (SIRT)3 contributes greatly to the prevention of redox stress and cell aging. The present study explored the role of SIRT3 on myocardium aging. Western blot analysis demonstrated that SIRT3 expression levels were significantly lower in the myocardia of aged mice compared with young mice. Immunoprecipitation and western blot assays indicated that the activity of mitochondrial manganese superoxide dismutase (MnSOD) and peroxisome proliferator-activated receptor coactivator (PGC)-1 was reduced in the aged heart. To further explore the association between SIRT3 and myocardial senescence, SIRT3 heart-specific knockout (SIRT3(-/-)) mice were used in the present study. The results revealed that obvious features of aging were present in the myocardium of SIRT3(-/-) mice, including mitochondrial protein dysfunction, enhanced oxidative stress, and energy metabolism dysfunction. SIRT3 deficiency impaired Parkin-mediated mitophagy by increasing p53-Parkin binding and blocking the mitochondrial translocation of Parkin in cardiomyocytes. Injection of autophagy agonist CCCP significantly increased the mitochondrial Parkin level in young wild-type hearts but not in aged hearts; the effect was less pronounced in SIRT3(-/-) hearts. These data suggest that CCCP-induced Parkin translocation was reduced in aged and SIRT3(-/-) hearts. CCCP-induced mitochondrial clearance, which could be rescued by autophagy antagonist bafilomycin-A1, was markedly weakened in aged and SIRT3(-/-) hearts vs. young hearts. SIRT3 deficiency exacerbated p53/Parkin-mediated mitophagy inhibition and disrupted mitochondrial homeostasis, suggesting that loss of SIRT3 may increase the susceptibility of aged hearts to cardiac dysfunction. Therapeutic activation of SIRT3 and improved mitochondrial function may ameliorate the symptoms of cardiac aging.

Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

Sirt3 Attenuates Oxidative Stress Damage and Rescues Cellular Senescence in Rat Bone Marrow Mesenchymal Stem Cells by Targeting Superoxide Dismutase 2

Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model.

SRT1720 Promotes Survival of Aged Human Mesenchymal Stem Cells Via FAIM: a Pharmacological Strategy to Improve Stem Cell-Based Therapy for Rat Myocardial Infarction

SIRT3 Deficiency Exacerbates P53/parkin‑mediated Mitophagy Inhibition and Promotes Mitochondrial Dysfunction: Implication for Aged Hearts

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

Abstract 10153: SIRT1 Activation Restores Cardioprotection in the Aged Heart Against Ischemia/Reperfusion Injury

SIRT1 Ameliorates Age-Related Senescence of Mesenchymal Stem Cells Via Modulating Telomere Shelterin

Roles of SIRT3 in Heart Failure: from Bench to Bedside.

Abstract 186: Impaired Nucleocytoplasmic Shuttling and Activity of SIRT1 in Response to Ischemic Stress in the Senescent Heart

Overexpression of ERBB4 Rejuvenates Aged Mesenchymal Stem Cells and Enhances Angiogenesis Via PI3K/AKT and MAPK/ERK Pathways

Mir-873-5p Suppression Reinvigorates Aging Mesenchymal Stem Cells and Improves Cardiac Repair after Myocardial Infarction.

SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation

AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs’ Dysfunction and Strengthened Anti-oxidant Capacity

S-sulfhydration of SIRT3 Combats BMSC Senescence and Ameliorates Osteoporosis Via Stabilizing Heterochromatic and Mitochondrial Homeostasis.

Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis

Advanced Age Impairs Cardioprotective Function of Mesenchymal Stem Cell Transplantation from Patients to Myocardially Infarcted Rats

Rescue of Mitochondrial SIRT3 Ameliorates Ischemia-like Injury in Human Endothelial Cells

Paracrine IGF-1 Activates SOD2 Expression and Regulates ROS/p53 Axis in the Treatment of Cardiac Damage in D-Galactose-Induced Aging Rats after Receiving Mesenchymal Stem Cells

Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease